164 related articles for article (PubMed ID: 32444775)
1. IDO1
Pflügler S; Svinka J; Scharf I; Crncec I; Filipits M; Charoentong P; Tschurtschenthaler M; Kenner L; Awad M; Stift J; Schernthanner M; Bischl R; Herndler-Brandstetter D; Glitzner E; Moll HP; Casanova E; Timelthaler G; Sibilia M; Gnant M; Lax S; Thaler J; Müller M; Strobl B; Mohr T; Kaser A; Trajanoski Z; Heller G; Eferl R
Commun Biol; 2020 May; 3(1):252. PubMed ID: 32444775
[TBL] [Abstract][Full Text] [Related]
2. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
[TBL] [Abstract][Full Text] [Related]
3. Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer.
Chen B; Alvarado DM; Iticovici M; Kau NS; Park H; Parikh PJ; Thotala D; Ciorba MA
Cancer Immunol Res; 2020 Apr; 8(4):451-464. PubMed ID: 32127391
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression Factors PD-1, PD-L1, and IDO1 and Colorectal Cancer.
Kovaleva OV; Rashidova MA; Gratchev AN; Maslennikov VV; Boulitcheva IV; Gershtein ES; Korotkova EA; Sokolov NY; Delektorskaya VV; Mamedli ZZ; Kushlinskii NE
Dokl Biochem Biophys; 2021 Mar; 497(1):66-70. PubMed ID: 33895919
[TBL] [Abstract][Full Text] [Related]
5. Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.
Moretti S; Menicali E; Nucci N; Voce P; Colella R; Melillo RM; Liotti F; Morelli S; Fallarino F; Macchiarulo A; Santoro M; Avenia N; Puxeddu E
J Biol Chem; 2017 Feb; 292(5):1785-1797. PubMed ID: 27994058
[TBL] [Abstract][Full Text] [Related]
6. Tyk2 is a tumor suppressor in colorectal cancer.
Moritsch S; Mödl B; Scharf I; Janker L; Zwolanek D; Timelthaler G; Casanova E; Sibilia M; Mohr T; Kenner L; Herndler-Brandstetter D; Gerner C; Müller M; Strobl B; Eferl R
Oncoimmunology; 2022; 11(1):2127271. PubMed ID: 36185806
[TBL] [Abstract][Full Text] [Related]
7. PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma.
Shu G; Chen M; Liao W; Fu L; Lin M; Gui C; Cen J; Lu J; Chen Z; Wei J; Chen W; Wang Y; Zhu J; Zhao T; Liu X; Jing J; Liu GC; Pan Y; Luo J; Zhang J
Cancer Res; 2024 May; 84(10):1659-1679. PubMed ID: 38382068
[TBL] [Abstract][Full Text] [Related]
8. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
[TBL] [Abstract][Full Text] [Related]
9. Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer.
Chen IC; Lee KH; Hsu YH; Wang WR; Chen CM; Cheng YW
Dis Markers; 2016; 2016():8169724. PubMed ID: 27578919
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer.
Liu X; Yan G; Xu B; Yu H; An Y; Sun M
Front Immunol; 2022; 13():1006501. PubMed ID: 36248886
[TBL] [Abstract][Full Text] [Related]
11. H
Yang D; Li T; Li Y; Zhang S; Li W; Liang H; Xing Z; Du L; He J; Kuang C; Yang Q
J Exp Clin Cancer Res; 2019 Feb; 38(1):88. PubMed ID: 30777103
[TBL] [Abstract][Full Text] [Related]
12. Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.
Günther C; Ruder B; Stolzer I; Dorner H; He GW; Chiriac MT; Aden K; Strigli A; Bittel M; Zeissig S; Rosenstiel P; Atreya R; Neurath MF; Wirtz S; Becker C
Gastroenterology; 2019 Nov; 157(5):1310-1322.e13. PubMed ID: 31352002
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.
Gomes B; Driessens G; Bartlett D; Cai D; Cauwenberghs S; Crosignani S; Dalvie D; Denies S; Dillon CP; Fantin VR; Guo J; Letellier MC; Li W; Maegley K; Marillier R; Miller N; Pirson R; Rabolli V; Ray C; Streiner N; Torti VR; Tsaparikos K; Van den Eynde BJ; Wythes M; Yao LC; Zheng X; Tumang J; Kraus M
Mol Cancer Ther; 2018 Dec; 17(12):2530-2542. PubMed ID: 30232146
[TBL] [Abstract][Full Text] [Related]
14. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
[TBL] [Abstract][Full Text] [Related]
15. IDO1 plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Hatano Y; Tomita H; Kuno T; Saito K; Hara A
J Immunol; 2013 Sep; 191(6):3057-64. PubMed ID: 23956437
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer.
Ferdinande L; Decaestecker C; Verset L; Mathieu A; Moles Lopez X; Negulescu AM; Van Maerken T; Salmon I; Cuvelier CA; Demetter P
Br J Cancer; 2012 Jan; 106(1):141-7. PubMed ID: 22108515
[TBL] [Abstract][Full Text] [Related]
17. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
[TBL] [Abstract][Full Text] [Related]
18. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells.
Campia I; Buondonno I; Castella B; Rolando B; Kopecka J; Gazzano E; Ghigo D; Riganti C
PLoS One; 2015; 10(5):e0126159. PubMed ID: 25955018
[TBL] [Abstract][Full Text] [Related]
19. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Ando T; Ito H; Hatano Y; Tomita H; Kuno T; Saito K; Seishima M; Hara A
Cancer Sci; 2015 Aug; 106(8):1008-15. PubMed ID: 26033215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
